Influenza vaccine uptake in adults aged 50-64 years: Policy and practice in England 2003/2004

被引:6
作者
Joseph, C
Elgohari, S
Nichols, T
Verlander, N
机构
[1] Hlth Protect Agcy Ctr Infect, Resp Dis Dept, London NW9 5EQ, England
[2] Hlth Protect Agcy Ctr Infect, State Modelling & Econ Dept, London NW9 5EQ, England
关键词
influenza; immunisation; vaccine uptake;
D O I
10.1016/j.vaccine.2005.10.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A small national study was carried out in England in 2003/2004 to ascertain the views of primary care trusts (PCTs) and general practitioners (GPs) on whether influenza immunisation should be extended to all people aged 50-64 years from the current recommendation of 65 years or more. Results showed that as many primary care trusts would be in favour, as would not be in favour. A similarly divided view was expressed by general practitioners. Vaccine uptake rates for high-risk (HR) and low-risk (LR) adults aged 50-64 years in the study population were higher in those practices where the GP was in favour of a more inclusive policy of offering flu vaccine to all persons aged 50 years or more, compared with those that did not favour this policy (60% versus 54% HR (p = 0.02) and 16% versus 11% LR (p = 0.02)). Higher rates of vaccine uptake for low-risk patients aged 50-64 years were also reported from practices where GPs perceived a greater health benefit of immunisation for this age group. Although policy for recommending vaccine to all patients aged 50 years or more is established elsewhere, opinion on whether such a policy should be adopted in England is currently divided amongst those providing local health services. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1786 / 1791
页数:6
相关论文
共 50 条
[41]   Sociodemographic disparities in COVID-19 and RSV vaccine uptake among California adults ≥60 years old who received influenza vaccination [J].
Rizzo, Kyle R. ;
Yen, Cynthia Jean ;
Quint, Joshua ;
Hoover, Cora ;
Schechter, Robert .
VACCINE, 2025, 62
[42]   Knowledge of influenza vaccination recommendation and early vaccination uptake during the 2015-16 season among adults aged ≥18 years - United States [J].
Lu, Peng-jun ;
Srivastav, Anup ;
Santibanez, Tammy A. ;
Stringer, M. Christopher ;
Bostwick, Michael ;
Dever, Jill A. ;
Kurtz, Marshica Stanley ;
Williams, Walter W. .
VACCINE, 2017, 35 (34) :4346-4354
[43]   Respiratory syncytial virus vaccine uptake among adults aged ≥60 years in a large, integrated healthcare system in Southern California 2023-2024 [J].
Patrick, Rudy ;
Mahale, Parag ;
Ackerson, Bradley K. ;
Hong, Vennis ;
Shaw, Sally ;
Kapadia, Banshri ;
Spence, Brigitte ;
Feaster, Matt ;
Slezak, Jeff ;
Stern, Julie A. ;
Davis, Gregg S. ;
Goodwin, Gabriella ;
Lewin, Bruno ;
Lewnard, Joseph A. ;
Tseng, Hung Fu ;
Tartof, Sara Y. .
VACCINE, 2025, 53
[44]   An Exploratory Assessment of Factors with Which Influenza Vaccine Uptake Is Associated in Hungarian Adults 65 Years Old and Older: Findings from European Health Interview Surveys [J].
Szollosi, Gergo Jozsef ;
Minh, Nguyen Chau ;
Santoso, Cornelia Melinda Adi ;
Zsuga, Judit ;
Nagy, Attila Csaba ;
Kardos, Laszlo .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (12)
[45]   Internet use habits and influenza vaccine uptake among US adults: results from seven years (2012-2018) of the National Health Interview Survey [J].
Khanijahani, A. ;
Calhoun, B. ;
Kiel, J. .
PUBLIC HEALTH, 2021, 195 :76-82
[46]   A randomised, clinical trial comparing the effectiveness of hospital and community-based reminder systems for increasing uptake of influenza and pneumococcal vaccine in hospitalised patients aged 65 years and over [J].
MacIntyre, CR ;
Kainer, MA ;
Brown, GV .
GERONTOLOGY, 2003, 49 (01) :33-40
[47]   Live-attenuated influenza vaccine effectiveness against hospitalization in children aged 2-6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14-2015/16 [J].
Boddington, Nicki L. ;
Mangtani, Punam ;
Zhao, Hongxin ;
Verlander, Neville Q. ;
Ellis, Joanna ;
Andrews, Nick ;
Pebody, Richard G. .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) :897-905
[48]   Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18–60 and >60 years: a randomized trial [J].
Xavier Duval ;
Adrian Caplanusi ;
Henri Laurichesse ;
Dominique Deplanque ;
Pierre Loulergue ;
Tejaswini Vaman ;
Odile Launay ;
Paul Gillard .
BMC Infectious Diseases, 12
[49]   Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019-20 Influenza Season-A Retrospective Cohort Analysis [J].
Levin, Myron J. ;
Divino, Victoria ;
Shah, Drishti ;
DeKoven, Mitch ;
Mould-Quevedo, Joaquin ;
Pelton, Stephen, I ;
Postma, Maarten J. .
VACCINES, 2021, 9 (10)
[50]   Immunogenicity and Safety of AS03-Adjuvanted H7N9 Influenza Vaccine in Adults (18-64 and ≥65 Years): A Phase 1/2, Randomized, Placebo-Controlled Trial [J].
Hastie, Andrew ;
Clarke, Tanya ;
Germain, Sophie ;
Ollinger, Thierry ;
Lese, Patricia ;
Gupta, Vinay .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (12)